BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncol 2001;37:193-8. [PMID: 11167148 DOI: 10.1016/s1368-8375(00)00079-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 71] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Grillo R. Analysis of the 100 most cited articles on ameloblastoma. Oral Maxillofac Surg 2022. [PMID: 35654987 DOI: 10.1007/s10006-022-01082-x] [Reference Citation Analysis]
2 Tseng C, Lu P, Wang Y, Chang JYF. Enrichment of SOX2-Positive Cells in BRAF V600E Mutated and Recurrent Ameloblastoma. JPM 2022;12:77. [DOI: 10.3390/jpm12010077] [Reference Citation Analysis]
3 Jabbarzadeh M, Hamblin MR, Pournaghi-Azar F, Vakili Saatloo M, Kouhsoltani M, Vahed N. Ki-67 expression as a diagnostic biomarker in odontogenic cysts and tumors: A systematic review and meta-analysis. J Dent Res Dent Clin Dent Prospects 2021;15:66-75. [PMID: 33927844 DOI: 10.34172/joddd.2021.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sivakumar M, Yoithapprabhunath TR, Nirmal RM, Veeravarmal V, Dineshshankar J, Amsaveni R. Immunohistochemical analysis of Nuclear Factor-kappa B (NF-κB) between follicular and plexiform ameloblastomas: A pilot study. J Oral Maxillofac Pathol 2020;24:466-71. [PMID: 33967482 DOI: 10.4103/jomfp.JOMFP_150_20] [Reference Citation Analysis]
5 Colmenares González DR, Peña Vega CP, Fajardo Ortiz LV. Expresión Inmunohistoquímica: Citoqueratinas CK19, CK14, β-Catenina y Ki67 en el Ameloblastoma y Queratoquiste Odontogénico. CES odontol 2020;33:86-99. [DOI: 10.21615/cesodon.33.2.8] [Reference Citation Analysis]
6 Gupta R, Chaudhary M, Patil S, Fating C, Hande A, Suryawanshi H. Expression of p63 in tooth germ, dentigerous cyst and ameloblastoma. J Oral Maxillofac Pathol 2019;23:43-8. [PMID: 31110415 DOI: 10.4103/jomfp.JOMFP_125_18] [Reference Citation Analysis]
7 Liu X, Chen Z, Lan T, Liang P, Tao Q. Upregulation of interleukin-8 and activin A induces osteoclastogenesis in ameloblastoma. Int J Mol Med 2019;43:2329-40. [PMID: 31017256 DOI: 10.3892/ijmm.2019.4171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
8 Acharya S, Arnold D, Prabhu P, Kc N, Hallikeri K. MCM-2 an alternative to Ki-67 for assessing cell proliferation in odontogenic pathologies. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2019;31:52-58. [DOI: 10.1016/j.ajoms.2018.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Indirapriyadarsini K, Raghunath V, Naidu BV, Ramakrishna BB, Tangudu A, Lokesh KV. Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma. J Oral Maxillofac Pathol 2018;22:446. [PMID: 30651703 DOI: 10.4103/jomfp.JOMFP_271_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 do Canto AM, Rozatto JR, Schussel JL, de Freitas RR, Hasséus B, Braz-Silva PH. Immunohistochemical biomarkers in ameloblastomas. Acta Odontol Scand 2016;74:585-90. [PMID: 27571891 DOI: 10.1080/00016357.2016.1224918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Ganvir SM, Khobragade PG, Bamane SA, Kumavat R, Dalmia A. Role of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study. J Oral Biol Craniofac Res 2016;6:187-93. [PMID: 27761382 DOI: 10.1016/j.jobcr.2016.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Singh T, Chandu A, Clement J, Angel C. Immunohistochemistry of Five Molecular Markers for Typing and Management of Ameloblastomas: A Retrospective Analysis of 40 Cases. J Maxillofac Oral Surg 2017;16:65-70. [PMID: 28286387 DOI: 10.1007/s12663-016-0923-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Sridhar M, Bhaskar Reddy LR, Kharat S, Mahesh BS, Gandi L, Mahendra A, Nigam P, Grewal P. Basal cell ameloblastoma: a rare histological variant of an uncommon tumor. Niger J Surg 2015;21:66-9. [PMID: 25838772 DOI: 10.4103/1117-6806.152730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Carreón-Burciaga RG, González-González R, Molina-Frechero N, Bologna-Molina R. Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns. Dis Markers 2015;2015:683087. [PMID: 26823641 DOI: 10.1155/2015/683087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
15 Yasuoka S, Kato T. <b>Histopathological and Immunohistochemical Characteristics of the Progressive Front of Ameloblastoma </b>. Int J Oral-Med Sci 2015;13:110-119. [DOI: 10.5466/ijoms.13.110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Varsha B, Gharat AL, Nagamalini B, Jyothsna M, Mothkur ST, Swaminathan U. Evaluation and comparison of expression of p63 in odontogenic keratocyst, solid ameloblastoma and unicystic ameloblastoma. J Oral Maxillofac Pathol. 2014;18:223-228. [PMID: 25328303 DOI: 10.4103/0973-029x.140755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
17 Bologna-Molina R, Bedoya-Borella AM, Soria-Moreira L, Soría-Suárez S. Molecular biomarkers of cell proliferation in ameloblastomas. World J Stomatol 2013; 2(4): 79-85 [DOI: 10.5321/wjs.v2.i4.79] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Razavi SM, Poursadeghi H, Aminzadeh A. Immunohistochemical comparison of cyclin D1 and P16 in odontogenic keratocyst and unicystic ameloblastoma. Dent Res J (Isfahan) 2013;10:180-3. [PMID: 23946733 DOI: 10.4103/1735-3327.113336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kanda S, Mitsuyasu T, Nakao Y, Kawano S, Goto Y, Matsubara R, Nakamura S. Anti-apoptotic role of the sonic hedgehog signaling pathway in the proliferation of ameloblastoma. Int J Oncol 2013;43:695-702. [PMID: 23835807 DOI: 10.3892/ijo.2013.2010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
20 Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, Mori-Estevez AD, Sánchez-Acuña G. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal 2013;18:e174-9. [PMID: 23229269 DOI: 10.4317/medoral.18573] [Cited by in Crossref: 132] [Cited by in F6Publishing: 150] [Article Influence: 13.2] [Reference Citation Analysis]
21 Gadbail AR, Patil R, Chaudhary M. Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor. Acta Odontol Scand 2012;70:529-35. [PMID: 21780975 DOI: 10.3109/00016357.2011.600714] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
22 Liu DX, Doyle LA, Bouljihad MT, Didier PJ, Gilbert MH, Wang X, Pahar B, Bohm RP, Veazey RS, Lackner AA. Locally infiltrative ameloblastic fibroma in a rhesus macaque (Macaca mulatta) with characterizations of its proliferating activity and biological behavior. J Vet Diagn Invest 2012;24:630-5. [PMID: 22529141 DOI: 10.1177/1040638712443359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Razavi SM, Tabatabaie SH, Hoseini AT, Hoseini ET, Khabazian A. A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor. Dent Res J (Isfahan) 2012;9:192-7. [PMID: 22623937 DOI: 10.4103/1735-3327.95235] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
24 Li Y, Han B, Li LJ. Prognostic and proliferative evaluation of ameloblastoma based on radiographic boundary. Int J Oral Sci 2012;4:30-3. [PMID: 22361946 DOI: 10.1038/ijos.2012.8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
25 Abdel-Aziz A, Amin MM. EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence. Diagn Pathol 2012;7:14. [PMID: 22300665 DOI: 10.1186/1746-1596-7-14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
26 Ye YK, Bi XC, He HC, Han ZD, Dai QS, Liang YX, Zeng GH, Qin WJ, Chen ZN, Zhong WD. CK20 and Ki-67 as significant prognostic factors in human bladder carcinoma. Clin Exp Med 2010;10:153-8. [PMID: 20069333 DOI: 10.1007/s10238-009-0088-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
27 Dhanuthai K, Chantarangsu S, Swasdison S. Proliferating Cell Nuclear Antigen Expression in Odontogenic Cysts and Ameloblastomas. Asian Journal of Oral and Maxillofacial Surgery 2005;17:6-10. [DOI: 10.1016/s0915-6992(05)80002-0] [Reference Citation Analysis]
28 Koizumi Y, Kauzman A, Okada H, Kuyama K, Mccomb RJ, Yamamoto H. Assessment of Proliferative Activity and Angiogenesis in Ameloblastoma : A Comparison Based on Patient Age. Int J Oral-Med Sci 2004;3:25-33. [DOI: 10.5466/ijoms.3.25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Miyake M, Koizumi Y, Utsunomiya T. A Histopathological and Immunohistochemical Study on Epithelial Proliferative Activity of Adenomatoid Odontogenic Tumor with Special Reference to Comparison with Ameloblastoma. Int J Oral-Med Sci 2004;3:10-19. [DOI: 10.5466/ijoms.3.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Hirayama T, Hamada T, Hasui K, Semba I, Murata F, Sugihara K. Immunohistochemical Analysis of Cell Proliferation and Suppression of Ameloblastoma with Special Reference to Plexiform and Follicular Ameloblastoma. Acta Histochem Cytochem 2004;37:391-8. [DOI: 10.1267/ahc.37.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
31 Sandra F. In reply to "Comment on: F. Sandra et al., The role of MDM2 in the proliferative activity of ameloblastoma", Oral Oncology 2002;38(2):153-7. Oral Oncol 2003;39:745. [PMID: 12907216 DOI: 10.1016/s1368-8375(03)00099-x] [Reference Citation Analysis]